NIH Wants to Repurpose Generic Drugs, but Who Will Pay?

The identification and initial prioritization of promising drug-repurposing opportunities were already addressed at a public workshop on August 5, organized by the Reagan-Udall Foundation for the FDA in collaboration with the Food and Drug Administration. 

Read more.